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Abstract—First specimens of 4-aryl-substituted tetrahydropyrimidin-2(1H)-ones containing a phosphoryl 
group were obtained through the reaction of 1-(3,3-diethoxypropyl)-1-[(dihexylphosphoryl)methyl]-3-
phenylurea with resorcinol and its derivatives in the presence of trifluoroacetic acid. 
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Development of methods for the synthesis of 
functionalized pyrimidin-2-one derivatives is of 
considerable interest for medical chemistry. Among 
the representatives of these heterocycles, selective α1a-
adrenergic receptor antagonists, Eg5 kinesin inhibitors 
[1], compounds exhibiting antihypertensive [2], anti-
inflammatory [3], and antiproliferative activity [4] were 
found. Introduction of the phosphoryl group to the struc-
ture of pyrimidin-2-ones can lead to increased pharma-
cological activity of these derivatives. To date, the method 
for producing phosphorylated dihydropyrimidines 
through the three-component condensation of aldehydes, 
urea, and O,O-dialkyl 2-oxopropanephosphonate in the 
presence of ytterbium triflate has been reported [5]. 
At the same time, β-ureidoacetals are promising 
synthons for the construction of six-membered hetero-
cycles. The only example of the condensation of                
β-ureidoacetal with 2,6-dimethylphenol in an acidic 
medium resulting in tetrahydropyrimidin-2-one with 
anti-inflammatory activity has been known[6]. 
Recently, we have developed methods for the 
synthesis of phosphorylated aminoacetals, synthons for 
the synthesis of phosphorylated aryl-substituted 
heterocycles [7, 8]. Here we report for the first time the 
synthesis of new phosphorus-containing tetrahydropyri-
midin-2-ones. Thus, the reaction of phosphorylated 
aminoacetal 1 with phenyl isocyanate afforded                    
β-ureidoacetal 2 containing a phosphine oxide group 
(Scheme 1). The acid-catalyzed condensation of 2 with 
resorcinol and its derivatives like pyrogallol, 2-
methylresorcinol or resorcinol in the presence of 3-fold 
excess of trifluoroacetic acid at room temperature for 
72 h furnished new phosphorylated tetrahydropyri-
midin-2-ones 4a–4c (Scheme 2).  
The structure of the obtained compounds was 
proved by 1H and 31P NMR, IR spectroscopy; the com-
position was confirmed by mass spectrometry and 
elemental analysis. 
Compound 1 was obtained by the previously 
described method [8]. 
1-(3,3-Diethoxypropyl)-1-[(dihexylphosphoryl)-
methyl]-3-phenylurea (2). Phenyl isocyanate (0.50 g) 
was added dropwise to a solution of 1.57 g of 
phosphine oxide 2 in 10 mL of benzene. The reaction 
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